Okta (OKTA) 10-Q 30 Nov 22 2023 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Oct. 31, 2022	Nov. 28, 2022
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2022
Document Transition Report	false
Entity File Number	001-38044
Entity Registrant Name	Okta, Inc.
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	100 First Street, Suite 600
Entity Tax Identification Number	26-4175727
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94105
City Area Code	888
Local Phone Number	722-7871
Title of 12(b) Security	Class A common stock, par value $0.0001 per share
Trading Symbol	OKTA
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Amendment Flag	false
Entity Central Index Key	0001660134
Current Fiscal Year End Date	--01-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Class A Common Stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		152,756,525
Class B Common Stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		7,426,641

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Current assets:
Cash and cash equivalents	$ 249,624	$ 260,134
Short-term investments	2,223,538	2,241,657
Accounts receivable, net of allowances of $7,609 and $4,359	380,754	397,509
Deferred commissions	84,454	74,728
Prepaid expenses and other current assets	68,567	66,605
Total current assets	3,006,937	3,040,633
Property and equipment, net	60,884	65,488
Operating lease right-of-use assets	125,207	147,940
Deferred commissions, noncurrent	195,146	191,029
Intangible assets, net	261,825	316,968
Goodwill	5,400,275	5,401,343
Other assets	43,462	42,294
Total assets	9,093,736	9,205,695
Current liabilities:
Accounts payable	49,122	20,203
Accrued expenses and other current liabilities	100,086	89,315
Accrued compensation	110,399	143,805
Convertible senior notes, net	5,217	16,194
Deferred revenue	1,044,622	973,289
Total current liabilities	1,309,446	1,242,806
Convertible senior notes, net, noncurrent	2,191,547	1,815,714
Operating lease liabilities, noncurrent	148,906	170,611
Deferred revenue, noncurrent	17,833	22,933
Other liabilities, noncurrent	18,392	31,775
Total liabilities	3,686,124	3,283,839
Commitments and contingencies (Note 11)
Stockholders’ equity:
Preferred stock, par value $0.0001 per share; 100,000 shares authorized; no shares issued and outstanding as of October 31, 2022 and January 31, 2022	0	0
Additional paid-in capital	7,785,753	7,749,716
Accumulated other comprehensive loss	(56,064)	(12,009)
Accumulated deficit	(2,322,093)	(1,815,867)
Total stockholders’ equity	5,407,612	5,921,856
Total liabilities and stockholders' equity	9,093,736	9,205,695
Class A Common Stock
Stockholders’ equity:
Common stock	15	15
Class B Common Stock
Stockholders’ equity:
Common stock	$ 1	$ 1

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Allowance for accounts receivable	$ 7,609	$ 4,359
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	100,000,000	100,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Class A Common Stock
Common stock par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	152,744,000	149,624,000
Common stock, shares outstanding (in shares)	152,744,000	149,624,000
Class B Common Stock
Common stock par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	120,000,000	120,000,000
Common stock, shares issued (in shares)	7,393,000	6,978,000
Common stock, shares outstanding (in shares)	7,393,000	6,978,000

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Revenue:
Total revenue	$ 481,042	$ 350,680	$ 1,347,792	$ 917,186
Cost of revenue:
Total cost of revenue	137,653	109,674	406,512	276,903
Gross profit	343,389	241,006	941,280	640,283
Operating expenses:
Research and development	148,484	130,535	465,971	321,805
Sales and marketing	289,984	203,878	807,110	548,749
General and administrative	111,520	105,149	322,549	322,406
Total operating expenses	549,988	439,562	1,595,630	1,192,960
Operating loss	(206,599)	(198,556)	(654,350)	(552,677)
Interest expense	(2,805)	(23,144)	(8,588)	(68,776)
Interest income and other, net	4,235	1,056	10,660	7,622
Loss on conversion of debt	0	0	0	(179)
Interest and other, net	1,430	(22,088)	2,072	(61,333)
Loss before provision for (benefit from) income taxes	(205,169)	(220,644)	(652,278)	(614,010)
Provision for (benefit from) income taxes	3,728	667	9,804	(6,785)
Net loss	$ (208,897)	$ (221,311)	$ (662,082)	$ (607,225)
Net loss per share, basic (in dollars per share)	$ (1.32)	$ (1.44)	$ (4.21)	$ (4.17)
Net loss per share, diluted (in dollars per share)	$ (1.32)	$ (1.44)	$ (4.21)	$ (4.17)
Weighted-average shares outstanding, basic (in shares)	158,708	153,756	157,344	145,782
Weighted-average shares outstanding, diluted (in shares)	158,708	153,756	157,344	145,782
Subscription
Revenue:
Total revenue	$ 465,856	$ 336,702	$ 1,299,181	$ 879,881
Cost of revenue:
Total cost of revenue	117,306	91,048	344,524	227,903
Professional services and other
Revenue:
Total revenue	15,186	13,978	48,611	37,305
Cost of revenue:
Total cost of revenue	$ 20,347	$ 18,626	$ 61,988	$ 49,000

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Statement of Comprehensive Income [Abstract]
Net loss	$ (208,897)	$ (221,311)	$ (662,082)	$ (607,225)
Other comprehensive loss:
Net change in unrealized gains or losses on available-for-sale securities	(7,896)	(2,998)	(26,595)	(4,164)
Foreign currency translation adjustments	(6,982)	(973)	(17,460)	(822)
Other comprehensive loss	(14,878)	(3,971)	(44,055)	(4,986)
Comprehensive loss	$ (223,775)	$ (225,282)	$ (706,137)	$ (612,211)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common stock and additional paid-in capital	Common stock and additional paid-in capital Adjustment	Accumulated deficit	Accumulated deficit Adjustment	Accumulated other comprehensive income
Beginning balance at Jan. 31, 2021		$ 1,656,109		$ (967,456)		$ 5,390
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock and value of equity awards assumed in connection with business combination		5,409,344
Issuance of common stock upon exercise of stock options and other activity, net		64,119
Stock-based compensation		408,482
Settlement of convertible senior notes		20,776
Proceeds from hedges related to convertible senior notes		2
Net loss	$ (607,225)			(607,225)
Other comprehensive loss						(4,986)
Ending balance at Oct. 31, 2021	5,984,555	7,558,832		(1,574,681)		404
Beginning balance at Jan. 31, 2021		1,656,109		(967,456)		5,390
Ending balance at Jan. 31, 2022	$ 5,921,856	7,749,732	$ (527,444)	(1,815,867)	$ 155,856	(12,009)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2020-06 [Member]
Beginning balance at Jul. 31, 2021		7,391,185		(1,353,370)		4,375
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options and other activity, net		11,208
Stock-based compensation		156,447
Settlement of convertible senior notes		(8)
Net loss	$ (221,311)			(221,311)
Other comprehensive loss						(3,971)
Ending balance at Oct. 31, 2021	5,984,555	7,558,832		(1,574,681)		404
Beginning balance at Jan. 31, 2022	5,921,856	7,749,732	$ (527,444)	(1,815,867)	$ 155,856	(12,009)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options and other activity, net		36,039
Stock-based compensation		515,507
Settlement of convertible senior notes		11,934
Proceeds from hedges related to convertible senior notes		1
Net loss	(662,082)			(662,082)
Other comprehensive loss						(44,055)
Ending balance at Oct. 31, 2022	5,407,612	7,785,769		(2,322,093)		(56,064)
Beginning balance at Jul. 31, 2022		7,607,398		(2,113,196)		(41,186)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options and other activity, net		6,088
Stock-based compensation		172,283
Settlement of convertible senior notes		0
Net loss	(208,897)			(208,897)
Other comprehensive loss						(14,878)
Ending balance at Oct. 31, 2022	$ 5,407,612	$ 7,785,769		$ (2,322,093)		$ (56,064)

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Cash flows from operating activities:
Net loss	$ (662,082)	$ (607,225)
Adjustments to reconcile net loss to net cash provided by operating activities:
Stock-based compensation	511,687	407,611
Depreciation, amortization and accretion	87,999	76,631
Amortization of debt discount and issuance costs	4,340	64,478
Amortization of deferred commissions	60,791	40,041
Deferred income taxes	3,383	(13,606)
Non-cash charitable contributions	2,469	5,649
Lease impairment charges	14,461	0
Loss on conversion of debt	0	179
Net gain on strategic investments	(1,873)	(5,665)
Other, net	1,872	(267)
Changes in operating assets and liabilities:
Accounts receivable	14,968	(29,561)
Deferred commissions	(82,589)	(92,183)
Prepaid expenses and other assets	(3,989)	5,356
Operating lease right-of-use assets	20,659	16,564
Accounts payable	29,794	(195)
Accrued compensation	(30,629)	19,488
Accrued expenses and other liabilities	(5,950)	22,537
Operating lease liabilities	(21,782)	(17,280)
Deferred revenue	66,233	198,035
Net cash provided by operating activities	9,762	90,587
Cash flows from investing activities:
Capitalization of internal-use software costs	(7,773)	(2,348)
Purchases of property and equipment	(9,377)	(5,800)
Purchases of securities available for sale and other	(872,035)	(1,333,504)
Proceeds from maturities and redemption of securities available for sale	848,519	1,118,448
Proceeds from sales of securities available for sale and other	0	228,344
Purchases of intangible assets	(2,497)	(113)
Payments for business acquisitions, net of cash acquired	(4,060)	(215,129)
Net cash used in investing activities	(47,223)	(210,102)
Cash flows from financing activities:
Payments for conversions of convertible senior notes	(6)	(26)
Proceeds from hedges related to convertible senior notes	1	2
Proceeds from stock option exercises	14,610	41,054
Proceeds from shares issued in connection with employee stock purchase plan	18,960	17,417
Net cash provided by financing activities	33,565	58,447
Effects of changes in foreign currency exchange rates on cash, cash equivalents and restricted cash	(9,747)	(494)
Net decrease in cash, cash equivalents and restricted cash	(13,643)	(61,562)
Cash, cash equivalents and restricted cash at beginning of period	272,656	448,630
Cash, cash equivalents and restricted cash at end of period	259,013	387,068
Cash paid during the period for:
Interest	3,509	3,548
Income taxes	5,445	2,550
Non-cash activities:
Issuance of common stock and value of equity awards assumed in connection with business combination	0	5,409,344
Issuance of common stock for conversions of convertible senior notes	39,564	126,144
Benefit from exercise of hedges related to convertible senior notes	17,502	92,097
Operating lease right-of-use assets exchanged for lease liabilities	8,442	21,518
Reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets to the amounts shown in the condensed consolidated statements of cash flows above:
Cash and cash equivalents	249,624	372,372
Restricted cash, current included in prepaid expenses and other current assets	2,204	5,136
Restricted cash, noncurrent included in other assets	7,185	9,560
Total cash, cash equivalents and restricted cash	$ 259,013	$ 387,068

Overview and Basis of Presentat

Overview and Basis of Presentation	9 Months Ended
	Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Overview and Basis of Presentation	Overview and Basis of Presentation Description of Business Okta, Inc. (the “Company”) is the leading independent identity provider. The Okta Workforce Identity and Customer Identity Clouds enable the Company’s customers to securely connect the right people to the right technologies and services at the right time. The Company was incorporated in January 2009 as Saasure Inc., a California corporation, and was later reincorporated in April 2010 under the name Okta, Inc. as a Delaware corporation. The Company is headquartered in San Francisco, California. Basis of Presentation and Principles of Consolidation The accompanying unaudited condensed consolidated financial statements, which include the accounts of the Company and its wholly owned subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim periods. Accordingly, they do not include all of the financial information and footnotes required by GAAP for complete financial statements. All intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated balance sheet as of January 31, 2022, included herein, was derived from the audited financial statements as of that date. In the opinion of the Company’s management, the unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary for a fair statement of the results of operations for the interim periods presented but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year ending January 31, 2023 or any future period. The Company’s fiscal year ends on January 31. References to fiscal 2023, for example, refer to the fiscal year ending January 31, 2023. The condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 7, 2022. Certain reclassifications of components of prior period investing cash flows have been made in the condensed consolidated statements of cash flows to conform to the current period presentation. These reclassifications had no impact on the aggregate cash flow classifications as previously reported. Use of Estimates

Accounting Standards and Signif

Accounting Standards and Significant Accounting Policies	9 Months Ended
	Oct. 31, 2022
Accounting Policies [Abstract]
Accounting Standards and Significant Accounting Policies	Accounting Standards and Significant Accounting Policies Significant Accounting Policies The Company’s significant accounting policies are discussed in “Note 2. Summary of Significant Accounting Policies” in Item 8. Financial Statements and Supplementary Data of its Form 10-K for the fiscal year ended January 31, 2022. The Company no longer considers the accounting policy for its convertible senior notes to be a significant accounting policy due to the adoption of Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) No. 2020-06 effective February 1, 2022, which simplified the accounting for convertible instruments. Recently Adopted Accounting Pronouncements ASU No. 2020-06 The Company adopted the FASB issued ASU No. 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), effective February 1, 2022, using the modified retrospective method. The prior period condensed consolidated financial statements have not been retrospectively adjusted and continue to be reported under the accounting standards in effect for those periods. ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity’s own equity. Among other changes, ASU 2020-06 removes from GAAP the liability and equity separation model for convertible instruments with a cash conversion feature, and as a result, after adoption, no longer requires separately presenting in equity an embedded conversion feature for such debt. Similarly, the embedded conversion feature is no longer amortized into income as interest expense over the life of the instrument. Instead, the convertible debt instrument is accounted for wholly as debt unless (1) a convertible instrument contains features that require bifurcation as a derivative, or (2) a convertible debt instrument was issued at a substantial premium. Additionally, ASU 2020-06 requires the application of the if-converted method to calculate the impact of convertible instruments on diluted earnings per share, which is consistent with the Company’s accounting treatment prior to the adoption of ASU 2020-06. The Company recognized a cumulative effect of initially applying the ASU as an adjustment to the February 1, 2022 opening balance of accumulated deficit. Due to the elimination of the equity conversion component of the Company’s convertible senior notes outstanding as of February 1, 2022, additional paid-in capital was reduced. The elimination of the equity conversion component had the effect of increasing the Company’s net debt balance. The reduction of other liabilities is related to changes to the Company’s deferred tax liabilities. The adoption of ASU 2020-06 resulted in the following changes to the Company’s condensed consolidated balance sheet as of February 1, 2022: Balance at Adjustments from Adoption of ASU 2020-06 Balance at (dollars in thousands) Liabilities Convertible senior notes, net $ 16,194 $ 927 $ 17,121 Convertible senior notes, net, noncurrent 1,815,714 371,527 2,187,241 Other liabilities, noncurrent 31,775 (866) 30,909 Stockholders’ equity Additional paid-in capital 7,749,716 (527,444) 7,222,272 Accumulated deficit (1,815,867) 155,856 (1,660,011) In addition, the adoption of ASU 2020-06 resulted in a decrease in reported net interest expense of approximately $21.2 million and $63.0 million and a decrease in basic and diluted net loss per share of $0.13 and $0.40, for the three and nine months ended October 31, 2022, respectively. ASU No. 2021-08 The Company adopted the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (“ASU 2021-08”), effective February 1, 2022, on a prospective basis. The update requires contract assets and contract liabilities acquired in a business combination be recognized and measured in accordance with ASC Topic 606, Revenue from Contracts with Customers. The adoption of ASU 2021-08 did not have a material impact on the Company’s condensed consolidated financial statements. ASU No. 2021-04 The Company adopted the FASB issued ASU No. 2021-04, Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (“ASU 2021-04”), effective February 1, 2022, on a prospective basis. ASU 2021-04 addresses specific guidance related to modifications or exchanges of freestanding equity-classified written call options (such as warrants) by specifying the accounting for various modification scenarios. The adoption of ASU 2021-04 did not have a material impact on the Company’s condensed consolidated financial statements.

Business Combinations

Business Combinations	9 Months Ended
	Oct. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Business Combinations	Business Combinations Acquisition of Auth0 On May 3, 2021, the Company acquired all outstanding shares of privately-held Auth0, Inc. (“Auth0”), an Identity-as-a-Service company. Total consideration transferred for Auth0 was $5,671.0 million, including approximately 19.2 million shares of common stock valued at $5,175.6 million, cash of $257.0 million, and assumed outstanding equity awards with vested fair value of $238.4 million. Cash consideration of $3.8 million and approximately 1.1 million shares valued at $294.6 million were held back as partial security for post-closing true-up adjustments as well as any indemnification claims made within one year of the acquisition date. The consideration held back was paid in full during the nine months ended October 31, 2022. The Company incurred $29.0 million of acquisition-related costs, which were recorded as general and administrative expenses in its condensed consolidated statement of operations for the nine months ended October 31, 2021. The transaction was accounted for as a business combination. The total purchase price of $5,671.0 million was allocated to the tangible and identifiable intangible assets and liabilities based on their estimated fair values. The excess of purchase consideration over the fair value of the net tangible assets and identifiable intangible assets acquired was $5,290.1 million and was recorded as goodwill. Acquisition of atSpoke On August 2, 2021, the Company acquired all issued and outstanding capital stock of privately-held Townsend Street Labs, Inc. (“atSpoke”), a modern workplace operations platform. The acquisition date cash consideration for atSpoke was approximately $79.3 million, of which $13.4 million of consideration was held back as partial security for any adjustments and indemnification obligations and will be paid within 18 months of the closing date.

Cash Equivalents and Investment

Cash Equivalents and Investments	9 Months Ended
	Oct. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Cash Equivalents and Investments	Cash Equivalents and Investments Cash Equivalents and Short-term Investments The following tables present the amortized cost, unrealized gain (loss) and estimated fair value of cash equivalents and short-term investments: As of October 31, 2022 Amortized Cost Unrealized Gain Unrealized Loss Estimated Fair Value (dollars in thousands) Cash equivalents: Money market funds $ 91,598 $ — $ — $ 91,598 Total cash equivalents 91,598 — — 91,598 Short-term investments: U.S. treasury securities 2,032,380 — (34,840) 1,997,540 Corporate debt securities 229,491 — (3,493) 225,998 Total short-term investments 2,261,871 — (38,333) 2,223,538 Total $ 2,353,469 $ — $ (38,333) $ 2,315,136 As of January 31, 2022 Amortized Cost Unrealized Gain Unrealized Loss Estimated Fair Value (dollars in thousands) Cash equivalents: Money market funds $ 152,223 $ — $ — $ 152,223 Total cash equivalents 152,223 — — 152,223 Short-term investments: U.S. treasury securities 1,922,344 10 (10,166) 1,912,188 Corporate debt securities 331,050 — (1,581) 329,469 Total short-term investments 2,253,394 10 (11,747) 2,241,657 Total $ 2,405,617 $ 10 $ (11,747) $ 2,393,880 All short-term investments were designated as available-for-sale securities as of October 31, 2022 and January 31, 2022. The following table presents the contractual maturities of the Company’s short-term investments: As of October 31, 2022 Amortized Cost Estimated Fair Value (dollars in thousands) Due within one year $ 1,925,930 $ 1,896,477 Due between one to five years 335,941 327,061 Total $ 2,261,871 $ 2,223,538 Interest receivable of $8.9 million and $6.0 million is included in Prepaid expenses and other current assets on the condensed consolidated balance sheets as of October 31, 2022 and January 31, 2022, respectively. The following table presents the fair values and unrealized losses related to the Company’s investments in available-for-sale debt securities classified by length of time that the securities have been in a continuous unrealized loss position as of October 31, 2022: Less Than 12 Months More Than 12 Months Total Estimated Fair Value Unrealized Losses Estimated Fair Value Unrealized Losses Estimated Fair Value Unrealized Losses (dollars in thousands) U.S. treasury securities $ 1,129,711 $ (19,305) $ 867,829 $ (15,535) $ 1,997,540 $ (34,840) Corporate debt securities 66,040 (1,035) 159,958 (2,458) 225,998 (3,493) Total $ 1,195,751 $ (20,340) $ 1,027,787 $ (17,993) $ 2,223,538 $ (38,333) The Company had 189 and 193 short-term investments in unrealized loss positions as of October 31, 2022 and January 31, 2022, respectively. For available-for-sale debt securities that have unrealized losses, the Company evaluates whether (i) the Company has the intention to sell any of these investments, (ii) it is not more likely than not that the Company will be required to sell any of these available-for-sale debt securities before recovery of the entire amortized cost basis and (iii) the decline in the fair value of the investment is due to credit or non-credit related factors. Based on this evaluation, the Company determined that for short-term investments, there were no material credit or non-credit related impairments as of October 31, 2022 and January 31, 2022. Strategic Investments

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Oct. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The Company measures its financial assets at fair value each reporting period using a fair value hierarchy that prioritizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Three levels of inputs may be used to measure as follows: Level 1—Valuations based on observable inputs that reflect quoted prices for identical assets or liabilities in active markets. Level 2—Valuations based on other inputs that are directly or indirectly observable in the marketplace. Level 3—Valuations based on unobservable inputs that are supported by little or no market activity. Assets and Liabilities Measured at Fair Value on a Recurring Basis The following tables present information about the Company’s financial assets that were measured at fair value on a recurring basis using the above input categories: As of October 31, 2022 Level 1 Level 2 Level 3 Total (dollars in thousands) Assets: Cash equivalents: Money market funds $ 91,598 $ — $ — $ 91,598 Total cash equivalents 91,598 — — 91,598 Short-term investments: U.S. treasury securities — 1,997,540 — 1,997,540 Corporate debt securities — 225,998 — 225,998 Total short-term investments — 2,223,538 — 2,223,538 Total cash equivalents and short-term investments $ 91,598 $ 2,223,538 $ — $ 2,315,136 As of January 31, 2022 Level 1 Level 2 Level 3 Total (dollars in thousands) Assets: Cash equivalents: Money market funds $ 152,223 $ — $ — $ 152,223 Total cash equivalents 152,223 — — 152,223 Short-term investments: U.S. treasury securities — 1,912,188 — 1,912,188 Corporate debt securities — 329,469 — 329,469 Total short-term investments — 2,241,657 — 2,241,657 Total cash equivalents and short-term investments $ 152,223 $ 2,241,657 $ — $ 2,393,880 The carrying amounts of certain financial instruments, including cash held in banks, accounts receivable and accounts payable, approximate fair value due to their short-term maturities and are excluded from the fair value tables above. Fair Value Measurements of Other Financial Instruments The following table presents the principal amounts and estimated fair values of the Company’s financial instruments that are not recorded at fair value on the condensed consolidated balance sheets: As of October 31, 2022 Principal Amount Estimated Fair Value (dollars in thousands) 2023 convertible senior notes $ 5,226 $ 6,001 2025 convertible senior notes 1,059,997 887,747 2026 convertible senior notes 1,150,000 925,635 The 2023 convertible senior notes (“2023 Notes”), the 2025 convertible senior notes (“2025 Notes”), and the 2026 convertible senior notes (“2026 Notes”, and together with the 2023 Notes and 2025 Notes, the “Notes”) are recorded at face value less unamortized debt issuance costs (See Note 9 for additional details). The estimated fair

Deferred Commissions

Deferred Commissions	9 Months Ended
	Oct. 31, 2022
Revenue from Contract with Customer [Abstract]
Deferred Commissions	Deferred CommissionsSales commissions capitalized as contract costs totaled $32.5 million and $35.7 million in the three months ended October 31, 2022 and 2021, respectively, and $81.9 million and $90.6 million in the nine months ended October 31, 2022 and 2021, respectively. Amortization of contract costs was $21.3 million and $14.9 million for the three months ended October 31, 2022 and 2021, respectively, and $60.8 million and $40.0 million for the nine months ended October 31, 2022 and 2021, respectively. Deferred Revenue and Performance Obligations Deferred Revenue Deferred revenue, which is a contract liability, consists primarily of payments received and accounts receivable recorded in advance of revenue recognition under the Company’s contracts with customers and is recognized as the revenue recognition criteria are met. Subscription revenue recognized during the three months ended October 31, 2022 and 2021 that was included in the deferred revenue balances at the beginning of the respective periods was $417.8 million and $299.9 million, respectively, and $858.0 million and $459.4 million in the nine months ended October 31, 2022 and 2021, respectively. Professional services and other revenue recognized during the three months ended October 31, 2022 and 2021 that was included in the deferred revenue balances at the beginning of the respective periods was $5.9 million and $4.5 million, respectively, and $12.9 million and $5.9 million in the nine months ended October 31, 2022 and 2021, respectively. Transaction Price Allocated to the Remaining Performance Obligations Transaction price allocated to the remaining performance obligations (“RPO”) represents all future, non-cancelable contracted revenue that has not yet been recognized, inclusive of deferred revenue that has been invoiced and non-cancelable amounts that will be invoiced and recognized as revenue in future periods. As of October 31, 2022, total remaining non-cancelable performance obligations under the Company’s subscription contracts with customers was approximately $2,852.8 million . Of this amount, the Company expects to recognize revenue of approximately $1,579.4 million, or 55%, over the next 12 months, with the balance to be recognized as revenue thereafter. Remaining performance obligations for professional services and other contracts as of October 31, 2022 were not material.

Goodwill and Intangible Assets,

Goodwill and Intangible Assets, net	9 Months Ended
	Oct. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets, net	Goodwill and Intangible Assets, net Goodwill As of October 31, 2022 and January 31, 2022, goodwill was $5,400.3 million and $5,401.3 million, respectively. No goodwill impairments were recorded during the three and nine months ended October 31, 2022 and 2021. Intangible Assets, net Intangible assets consisted of the following: As of October 31, 2022 Gross Accumulated Amortization Net (dollars in thousands) Capitalized internal-use software costs $ 48,016 $ (28,607) $ 19,409 Purchased developed technology 219,800 (81,187) 138,613 Customer relationships 140,900 (52,798) 88,102 Trade name 21,400 (6,420) 14,980 Software licenses 1,797 (1,076) 721 $ 431,913 $ (170,088) $ 261,825 As of January 31, 2022 Gross Accumulated Amortization Net (dollars in thousands) Capitalized internal-use software costs $ 36,319 $ (24,170) $ 12,149 Purchased developed technology 219,100 (47,085) 172,015 Customer relationships 140,900 (26,399) 114,501 Trade name 21,400 (3,210) 18,190 Software licenses 116 (3) 113 $ 417,835 $ (100,867) $ 316,968 The weighted-average remaining useful lives of the Company’s acquired intangible assets are as follows: Weighted-Average Remaining Useful Life As of October 31, 2022 As of January 31, 2022 Purchased developed technology 3.3 years 4.0 years Customer relationships 3.5 years 4.0 years Trade name 3.5 years 4.3 years Amortization expense of intangible assets for the three months ended October 31, 2022 and 2021 was $23.3 million and $22.4 million, respectively, and $69.2 million and $46.6 million for the nine months ended October 31, 2022 and 2021, respectively.

Deferred Revenue and Performanc

Deferred Revenue and Performance Obligations	9 Months Ended
	Oct. 31, 2022
Revenue from Contract with Customer [Abstract]
Deferred Revenue and Performance Obligations	Deferred CommissionsSales commissions capitalized as contract costs totaled $32.5 million and $35.7 million in the three months ended October 31, 2022 and 2021, respectively, and $81.9 million and $90.6 million in the nine months ended October 31, 2022 and 2021, respectively. Amortization of contract costs was $21.3 million and $14.9 million for the three months ended October 31, 2022 and 2021, respectively, and $60.8 million and $40.0 million for the nine months ended October 31, 2022 and 2021, respectively. Deferred Revenue and Performance Obligations Deferred Revenue Deferred revenue, which is a contract liability, consists primarily of payments received and accounts receivable recorded in advance of revenue recognition under the Company’s contracts with customers and is recognized as the revenue recognition criteria are met. Subscription revenue recognized during the three months ended October 31, 2022 and 2021 that was included in the deferred revenue balances at the beginning of the respective periods was $417.8 million and $299.9 million, respectively, and $858.0 million and $459.4 million in the nine months ended October 31, 2022 and 2021, respectively. Professional services and other revenue recognized during the three months ended October 31, 2022 and 2021 that was included in the deferred revenue balances at the beginning of the respective periods was $5.9 million and $4.5 million, respectively, and $12.9 million and $5.9 million in the nine months ended October 31, 2022 and 2021, respectively. Transaction Price Allocated to the Remaining Performance Obligations Transaction price allocated to the remaining performance obligations (“RPO”) represents all future, non-cancelable contracted revenue that has not yet been recognized, inclusive of deferred revenue that has been invoiced and non-cancelable amounts that will be invoiced and recognized as revenue in future periods. As of October 31, 2022, total remaining non-cancelable performance obligations under the Company’s subscription contracts with customers was approximately $2,852.8 million . Of this amount, the Company expects to recognize revenue of approximately $1,579.4 million, or 55%, over the next 12 months, with the balance to be recognized as revenue thereafter. Remaining performance obligations for professional services and other contracts as of October 31, 2022 were not material.

Convertible Senior Notes, Net

Convertible Senior Notes, Net	9 Months Ended
	Oct. 31, 2022
Debt Disclosure [Abstract]
Convertible Senior Notes, Net	Convertible Senior Notes, Net 2023 Convertible Senior Notes The 2023 Notes are senior, unsecured obligations of the Company, and bear interest at a fixed rate of 0.25% per year. Interest is payable in cash semi-annually in arrears on February 15 and August 15 of each year, beginning on August 15, 2018. The 2023 Notes mature on February 15, 2023 unless earlier repurchased or converted. The Company may not redeem the 2023 Notes prior to maturity. There have been no changes to the terms of the 2023 Notes, Note Hedges (as defined below), or Warrants (as defined below) from those disclosed in the Company’s Form 10-K for the fiscal year ended January 31, 2022. The 2023 Notes are currently convertible at the option of the holders, in whole or in part, as of October 15, 2022 until the close of business on the second scheduled trading day immediately preceding the maturity date, regardless of the conversion conditions. The 2023 Notes are classified as current liabilities on the condensed consolidated balance sheet as of October 31, 2022. As of October 31, 2022, $5.2 million of principal remained outstanding on the 2023 Notes. During the three months ended October 31, 2022, the Company did not settle any of the 2023 Notes and during the nine months ended October 31, 2022, the Company issued approximately 0.2 million shares of Class A common stock and paid an immaterial amount in cash to settle approximately $12.0 million principal amount of 2023 Notes. During the year ended January 31, 2022, the Company issued approximately 0.5 million shares of Class A common stock and paid an immaterial amount in cash to settle approximately $23.0 million principal amount of 2023 Notes. As of October 31, 2022, the effective interest rate on the 2023 Notes was 0.85%. As of October 31, 2021, prior to the adoption of ASU 2020-06, the effective interest rate on the liability component of the 2023 Notes was 5.68%. The following table sets forth total interest expense recognized related to the 2023 Notes: Three Months Ended Nine Months Ended 2022 2021 2022 2021 (dollars in thousands) Contractual interest expense $ 3 $ 9 $ 14 $ 43 Amortization of debt issuance costs 8 22 35 84 Amortization of debt discount (1) — 213 — 837 Total $ 11 $ 244 $ 49 $ 964 (1) Not applicable subsequent to adoption of ASU 2020-06. The net carrying amount of the 2023 Notes consisted of the following: As of October 31, 2022 As of January 31, 2022 (dollars in thousands) Liability component: Principal $ 5,226 $ 17,228 Less: unamortized debt issuance costs and debt discount (1) (9) (1,034) Net carrying amount $ 5,217 $ 16,194 As of October 31, 2022 As of January 31, 2022 (dollars in thousands) Equity component: (1) 2023 Notes $ — $ 3,993 Less: issuance costs — (116) Carrying amount of the equity component (2) $ — $ 3,877 (1) Subsequent to the adoption of ASU 2020-06 under the modified retrospective method, the equity component and debt discount are eliminated. (2) Included in the January 31, 2022 condensed consolidated balance sheet within Additional paid-in capital. Note Hedges In connection with the pricing of the 2023 Notes, the Company entered into convertible note hedges with respect to its Class A common stock (the “Note Hedges”). The Note Hedges are purchased call options that give the Company the option to purchase shares, subject to anti-dilution adjustments substantially identical to those in the 2023 Notes, of its Class A common stock for approximately $48.36 per share (subject to adjustment), corresponding to the approximate initial conversion price of the 2023 Notes, exercisable upon conversion of the 2023 Notes. The Note Hedges will expire in 2023, if not exercised earlier. The Note Hedges are separate transactions and are not part of the terms of the 2023 Notes. During the three months ended October 31, 2022, the Company did not settle any Note Hedges and during the nine months ended October 31, 2022, the Company exercised and net-share-settled Note Hedges corresponding to approximately $12.0 million principal amount of 2023 Notes and received approximately 0.1 million shares of Class A common stock and an immaterial cash payment. As of October 31, 2022, Note Hedges giving the Company the option to purchase approximately 0.1 million shares (subject to adjustment) remained outstanding. Warrants In connection with the issuance of the 2023 Notes, the Company entered into separate warrant transactions pursuant to which it sold net-share-settled (or, at the Company’s election subject to certain conditions, cash-settled) warrants (the “Warrants”) to acquire shares, subject to anti-dilution adjustments, over 80 scheduled trading days beginning in May 2023 of the Company’s Class A common stock at an initial exercise price of approximately $68.06 per share (subject to adjustment). The Warrants are separate transactions and are not part of the terms of the 2023 Notes or the Note Hedges. As of October 31, 2022, Warrants to acquire up to approximately 1.0 million shares (subject to adjustment) remained outstanding. 2025 Convertible Senior Notes The 2025 Notes are senior, unsecured obligations of the Company, and bear interest at a fixed rate of 0.125% per year. Interest is payable in cash semi-annually in arrears on March 1 and September 1 of each year, beginning on March 1, 2020. The 2025 Notes mature on September 1, 2025 unless earlier redeemed, repurchased or converted. There have been no changes to the terms of the 2025 Notes or 2025 Capped Calls (as defined below) from those disclosed in the Company’s Form 10-K for the fiscal year ended January 31, 2022. As of October 31, 2022, the conditions allowing holders of the 2025 Notes to convert were not met, and as a result, the 2025 Notes were classified as noncurrent liabilities on the condensed consolidated balance sheet. As of October 31, 2022, the effective interest rate on the 2025 Notes was 0.43%. As of October 31, 2021, prior to the adoption of ASU 2020-06, the effective interest rate on the liability component of the 2025 Notes was 4.10%. The following table sets forth total interest expense recognized related to the 2025 Notes: Three Months Ended Nine Months Ended 2022 2021 2022 2021 (dollars in thousands) Contractual interest expense $ 332 $ 332 $ 994 $ 994 Amortization of debt issuance costs 809 581 2,424 1,705 Amortization of debt discount (1) — 8,878 — 26,368 Total $ 1,141 $ 9,791 $ 3,418 $ 29,067 (1) Not applicable subsequent to adoption of ASU 2020-06. The net carrying amount of the 2025 Notes consisted of the following: As of October 31, 2022 As of January 31, 2022 (dollars in thousands) Liability component: Principal $ 1,059,997 $ 1,059,997 Less: unamortized debt issuance costs and debt discount (1) (9,239) (149,333) Net carrying amount $ 1,050,758 $ 910,664 As of October 31, 2022 As of January 31, 2022 (dollars in thousands) Equity component: (1) 2025 Notes $ — $ 221,387 Less: issuance costs — (4,040) Carrying amount of the equity component (2) $ — $ 217,347 (1) Subsequent to the adoption of ASU 2020-06 under the modified retrospective method, the equity component and debt discount are eliminated. (2) Included in the January 31, 2022 condensed consolidated balance sheet within Additional paid-in capital. 2025 Capped Calls In connection with the pricing of the 2025 Notes, the Company entered into capped call transactions with respect to its Class A common stock (the “2025 Capped Calls”). The 2025 Capped Calls are purchased call options that give the Company the option to purchase approximately 5.6 million shares, subject to anti-dilution adjustments substantially identical to those in the 2025 Notes, of its Class A common stock for approximately $188.71 per share (subject to adjustment), corresponding to the approximate initial conversion price of the 2025 Notes, exercisable upon conversion of the 2025 Notes. The 2025 Capped Calls have initial cap prices of $255.88 per share (subject to adjustment) and will expire in 2025, if not exercised earlier. The 2025 Capped Calls are separate transactions and are not part of the terms of the 2025 Notes. 2026 Convertible Senior Notes The 2026 Notes are senior, unsecured obligations of the Company, and bear interest at a fixed rate of 0.375% per year. Interest is payable in cash semi-annually in arrears on June 15 and December 15 of each year, beginning on December 15, 2020. The 2026 Notes mature on June 15, 2026 unless earlier redeemed, repurchased or converted. There have been no changes to the terms of the 2026 Notes or 2026 Capped Calls (as defined below) from those disclosed in the Company’s Form 10-K for the fiscal year ended January 31, 2022. As of October 31, 2022, the conditions allowing holders of the 2026 Notes to convert were not met, and as a result, the 2026 Notes were classified as noncurrent liabilities on the condensed consolidated balance sheet. As of October 31, 2022, the effective interest rate on the 2026 Notes was 0.60%. As of October 31, 2021, prior to the adoption of ASU 2020-06, the effective interest rate on the liability component of the 2026 Notes was 5.75%. The following table sets forth total interest expense recognized related to the 2026 Notes: Three Months Ended Nine Months Ended 2022 2021 2022 2021 (dollars in thousands) Contractual interest expense $ 1,078 $ 1,078 $ 3,234 $ 3,234 Amortization of debt issuance costs 628 364 1,881 1,056 Amortization of debt discount (1) — 11,640 — 34,428 Total $ 1,706 $ 13,082 $ 5,115 $ 38,718 (1) Not applicable subsequent to adoption of ASU 2020-06. The net carrying amount of the 2026 Notes consisted of the following: As of October 31, 2022 As of January 31, 2022 (dollars in thousands) Liability component: Principal $ 1,150,000 $ 1,150,000 Less: unamortized debt issuance costs and debt discount (1) (9,211) (244,950) Net carrying amount $ 1,140,789 $ 905,050 As of October 31, 2022 As of January 31, 2022 (dollars in thousands) Equity component: (1) 2026 Notes $ — $ 310,311 Less: issuance costs — (4,090) Carrying amount of the equity component (2) $ — $ 306,221 (1) Subsequent to the adoption of ASU 2020-06 under the modified retrospective method, the equity component and debt discount are eliminated. (2) Included in the January 31, 2022 condensed consolidated balance sheet within Additional paid-in capital. 2026 Capped Calls In connection with the pricing of the 2026 Notes, the Company entered into capped call transactions with respect to its Class A common stock (the “2026 Capped Calls”). The 2026 Capped Calls are purchased call options that give the Company the option to purchase approximately 4.8 million shares, subject to anti-dilution adjustments substantially identical to those in the 2026 Notes, of its Class A common stock for approximately $238.60 per share (subject to adjustment), corresponding to the approximate initial conversion price of the 2026 Notes, exercisable upon conversion of the 2026 Notes. The 2026 Capped Calls have initial cap prices of $360.14 per share (subject to adjustment) and will expire in 2026, if not exercised earlier. The 2026 Capped Calls are separate transactions and are not part of the terms of the 2026 Notes.

Leases

Leases	9 Months Ended
	Oct. 31, 2022
Leases [Abstract]
Leases	LeasesThe Company has entered into various non-cancelable office space operating leases with original lease periods expiring between 2022 and 2029. These leases do not contain material variable rent payments, residual value guarantees, financial covenants or other restrictions. Operating lease costs were as follows: Three Months Ended Nine Months Ended 2022 2021 2022 2021 (dollars in thousands) Operating lease cost (1) $ 10,218 $ 9,677 $ 30,954 $ 28,135 (1) Amounts are presented exclusive of sublease income and include leases with an original term of 12 months or less (short-term leases), which are immaterial. The weighted-average remaining term of the Company’s operating leases was 5.3 years and 5.9 years as of October 31, 2022 and January 31, 2022, respectively, and the weighted-average discount rate used to measure the present value of the operating lease liabilities was 5.3% and 5.5%, respectively. Maturities of the Company’s operating lease liabilities, which do not include short-term leases, are as follows: As of October 31, 2022 Fiscal Year Ending January 31: (dollars in thousands) 2023 (remaining three months) $ 11,367 2024 44,971 2025 41,540 2026 31,309 2027 30,500 Thereafter 53,608 Total lease payments 213,295 Less imputed interest (27,876) Less tenant improvement allowances not yet recognized (1,979) Total operating lease liabilities $ 183,440 Cash payments made related to operating lease liabilities were $11.3 million and $10.3 million in the three months ended October 31, 2022 and 2021, respectively, and $29.5 million and $29.4 million in the nine months ended October 31, 2022 and 2021, respectively. During the three months ended October 31, 2022, the Company announced a real estate optimization plan which provided for closing duplicative sites and decommissioning underutilized offices and floors. As a result, the Company recognized $14.2 million of non-cash lease impairment charges included in general and administrative expenses on the condensed consolidated statement of operations for the three months ended October 31, 2022. The non-cash lease impairment charges represent the amount that the carrying value of the asset groups exceeded their estimated fair values. The asset groups primarily include operating lease right-of-use assets, leasehold improvements, and related property and equipment. To estimate the fair value of the asset group, the Company utilized a discounted cash flow approach using market participant assumptions of the expected cash flows and discount rate.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Oct. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Letters of Credit In conjunction with the execution of certain office space operating leases, letters of credit in the aggregate amount of $8.5 million and $8.6 million were issued and outstanding as of October 31, 2022 and January 31, 2022, respectively. No draws have been made under such letters of credit. Noncurrent restricted cash of $6.3 million and $6.4 million associated with these letters of credit is included in Other assets on the condensed consolidated balance sheets as of October 31, 2022 and January 31, 2022, respectively. Purchase Obligations Except as discussed below, there were no significant changes in future minimum purchase obligations as disclosed in the Company’s audited consolidated financial statements for the year ended January 31, 2022. Effective July 2022, the Company terminated its existing agreement and entered into a new agreement with a cloud services provider with a total obligation of $450.0 million over a four-year period. Legal Matters From time to time in the normal course of business, the Company may be subject to various legal matters such as threatened or pending claims or proceedings. There were no such material matters as of October 31, 2022. Warranties and Indemnification To date, the Company has not incurred significant costs and has not accrued any material liabilities in the accompanying condensed consolidated financial statements as a result of its warranty and indemnification obligations.

Employee Incentive Plans

Employee Incentive Plans	9 Months Ended
	Oct. 31, 2022
Share-Based Payment Arrangement [Abstract]
Employee Incentive Plans	Employee Incentive Plans The Company’s equity incentive plans provide for granting stock options, restricted stock units (“RSUs”), restricted stock awards to employees, consultants, officers and directors and restricted stock units with market-based vesting conditions to certain executives. In addition, the Company offers an Employee Stock Purchase Plan (“ESPP”) to eligible employees. Stock-based compensation expense was recorded in the following cost and expense categories in the Company’s condensed consolidated statements of operations: Three Months Ended Nine Months Ended 2022 2021 2022 2021 (dollars in thousands) Cost of revenue Subscription $ 17,106 $ 13,455 $ 51,509 $ 33,843 Professional services and other 3,563 3,376 11,016 8,879 Research and development 69,208 56,573 208,330 129,998 Sales and marketing 41,515 39,248 120,299 101,602 General and administrative 39,593 43,133 120,533 133,289 Total $ 170,985 $ 155,785 $ 511,687 $ 407,611 Equity Incentive Plans The Company has two equity incentive plans: the 2009 Stock Plan and the 2017 Equity Incentive Plan (“2017 Plan”). In addition, the Company assumed Auth0 equity incentive plans. All shares that remain available for future grants are under the 2017 Plan. As of October 31, 2022, options to purchase 1,841,836 shares of Class A common stock and 4,787,688 shares of Class B common stock remained outstanding. Shares of common stock reserved for future issuance are as follows: As of October 31, 2022 Stock options and unvested RSUs outstanding 15,807,738 Available for future stock option and RSU grants 26,022,656 Available for ESPP 7,053,433 48,883,827 Stock Options A summary of the Company’s stock option activity and related information is as follows: Number of Options Weighted- Average Exercise Price Weighted- Average Remaining Contractual Term (Years) Aggregate Intrinsic Value (in thousands) Outstanding as of January 31, 2022 7,984,078 $ 39.59 5.2 $ 1,314,031 Granted — — Exercised (1,177,880) 12.41 Expired (24,833) 195.71 Forfeited (151,841) 62.73 Outstanding as of October 31, 2022 6,629,524 $ 43.30 4.6 $ 249,207 As of October 31, 2022 Vested and exercisable 5,855,640 $ 27.07 4.1 $ 242,916 As of October 31, 2022, there was a total of $112.5 million of unrecognized stock-based compensation expense related to options, which is being recognized over a weighted-average period of 1.9 years. Restricted Stock Units A summary of the Company’s RSU activity (inclusive of market-based RSUs) and related information is as follows: Number of Weighted- Outstanding as of January 31, 2022 6,225,747 $ 207.26 Granted 6,087,249 121.08 Vested (1,956,194) 177.54 Forfeited (1,178,588) 195.91 Outstanding as of October 31, 2022 9,178,214 $ 157.90 As of October 31, 2022, there was $1,304.0 million of unrecognized stock-based compensation expense related to unvested RSUs, which is being recognized over a weighted-average period of 3.1 years based on vesting under the award service conditions. Market-based Restricted Stock Units In March 2022, the Company granted market-based RSUs to certain members of management. The target number of market-based RSUs granted was 58,150. One-third of these market-based RSUs vest over each of a one-, two- and three-year performance period, each starting on February 1, 2022. The number of shares that can be earned ranges from 0% to 200% of the target number of shares based on the relative performance of the per share price of the Company’s common stock as compared to the Nasdaq Composite Index over the respective performance periods and subject to continuous employment through the vesting dates. The $244.73 grant date fair value per target market-based RSU was determined using a Monte Carlo simulation approach. Compensation expense for awards with market conditions is recognized over the service period using the accelerated attribution method and is not reversed if the market condition is not met. Restricted Stock Awards Issued in Connection with Business Combinations In fiscal year 2022, the Company entered into revesting agreements with the founders of the acquired businesses pursuant to which 1,269,008 restricted shares of Okta’s Class A common stock with a weighted-average fair value per share of $268.98 issued as of the respective closing dates will vest over 3 years. In connection with the business combinations, as of October 31, 2022, there was $172.4 million of unrecognized stock-based compensation expense related to unvested restricted shares, which is being recognized over a weighted-average period of 1.5 years based on vesting under the award service conditions. Employee Stock Purchase Plan The ESPP provides for 12-month offering periods beginning June 21 and December 21 of each year, and each offering period consists of up to two six-month purchase periods. The ESPP contains a reset provision under which the offering period resets if the fair market value of the Company’s common stock on the purchase date is less than the fair market value on the offering date. The Company estimated the fair value of ESPP purchase rights using a Black-Scholes option pricing model with the following assumptions: Three Months Ended Nine Months Ended 2022 2021 2022 2021 Expected volatility —%- —% —% - —% 63% - 78% 47% - 48% Expected term (in years) 0 - 0 0 - 0 0.5 - 1.0 0.5 - 1.0 Risk-free interest rate —% - —% —% - —% 2.46% - 2.92% 0.06% - 0.09% Expected dividend yield — — — — During the nine months ended October 31, 2022, the Company’s employees purchased 269,814 shares of its Class A common stock under the ESPP. The shares were purchased at a weighted-average purchase price of $70.27 per share, with total proceeds of $19.0 million. As of October 31, 2022, there was $15.2 million of unrecognized stock-based compensation expense related to the ESPP that is expected to be recognized over a weighted-average vesting period of 0.6 years.

Income Taxes

Income Taxes	9 Months Ended
	Oct. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes For the three and nine months ended October 31, 2022, the Company recorded a tax provision of $3.7 million and $9.8 million on pretax losses of $205.2 million and $652.3 million, respectively. The effective tax rate for the three and nine months ended October 31, 2022 was approximately (1.8)% and (1.5)%, respectively. The effective tax rate differs from the statutory rate primarily as a result of not recognizing the tax benefit for U.S. losses due to a full valuation allowance against U.S. deferred tax assets, the tax effect of foreign operations, U.S. state taxes, and stock-based compensation shortfalls in the United Kingdom. The Tax Cuts and Jobs Act enacted on December 22, 2017 amended Internal Revenue Code Section 174 to require that specific research and experimental (“R&E”) expenditures be capitalized and amortized over five years (U.S. R&E) or fifteen years (non-U.S. R&E) beginning in the Company's fiscal 2023. Although Congress has considered legislation that would defer, modify or repeal the capitalization and amortization requirement, to date the provision has not been deferred, repealed or otherwise modified. As a result, the Company may be required to utilize some of its federal and state tax attributes and there may be increases to cash taxes or tax expense. For the three and nine months ended October 31, 2021, the Company recorded a tax provision of $0.7 million and a tax benefit of $6.8 million on pretax losses of $220.6 million and $614.0 million, respectively. The effective tax rate for the three and nine months ended October 31, 2021 was approximately (0.3)% and 1.1%, respectively. The effective tax rate differs from the statutory rate primarily as a result of not recognizing deferred tax assets for U.S. losses due to a full valuation allowance against U.S. deferred tax assets, release of the valuation allowance in the United States in connection with the acquired businesses, a remeasurement of deferred tax assets in connection with a tax rate change in the United Kingdom, and excess tax benefits from stock-based compensation in the United

Net Loss Per Share

Net Loss Per Share	9 Months Ended
	Oct. 31, 2022
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss Per Share The following table presents the calculation of basic and diluted net loss per share: Three Months Ended Nine Months Ended 2022 2021 2022 2021 Class A Class B Class A Class B Class A Class B Class A Class B (dollars in thousands, except per share data) Numerator: Net loss $ (199,456) $ (9,441) $ (211,176) $ (10,135) $ (632,425) $ (29,657) $ (576,106) $ (31,119) Denominator: Weighted-average shares outstanding, basic and diluted 151,535 7,173 146,715 7,041 150,296 7,048 138,311 7,471 Net loss per share, basic and diluted $ (1.32) $ (1.32) $ (1.44) $ (1.44) $ (4.21) $ (4.21) $ (4.17) $ (4.17) As the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share as the inclusion of all potential common shares outstanding would have been anti-dilutive. Potentially dilutive securities that are not included in the diluted per share calculations because they would be anti-dilutive are as follows: As of October 31, 2022 2021 (in thousands) Issued and outstanding stock options 6,630 8,621 Unvested RSUs issued and outstanding 9,120 5,221 Unvested market-based RSUs issued and outstanding 116 — Unvested restricted stock awards issued and outstanding 743 1,269 Shares committed under the ESPP 597 213 Shares related to the 2023 Notes 108 356 Shares subject to warrants related to the issuance of the 2023 Notes 1,048 1,048 Shares related to the 2025 Notes 5,617 5,617 Shares related to the 2026 Notes 4,820 4,820 28,799 27,165 The Company uses the if-converted method for calculating any potential dilutive effect of the conversion options embedded in the Notes on diluted net income per share, if applicable. The conversion options of the 2023 Notes, 2025 Notes and 2026 Notes are dilutive in periods of net income on a weighted-average basis using an assumed conversion date equal to the later of the beginning of the reporting period and the date of issuance of the respective Notes. The exercise rights of the Warrants will have a dilutive impact on net income per share of common stock under the treasury-stock method when the average market price per share of the Company’s Class A common stock for a given period exceeds the conversion price of $68.06 per share.

Accounting Standards and Sign_2

Accounting Standards and Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	The accompanying unaudited condensed consolidated financial statements, which include the accounts of the Company and its wholly owned subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim periods. Accordingly, they do not include all of the financial information and footnotes required by GAAP for complete financial statements.
Principles of Consolidation	All intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated balance sheet as of January 31, 2022, included herein, was derived from the audited financial statements as of that date. In the opinion of the Company’s management, the unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary for a fair statement of the results of operations for the interim periods presented but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year ending January 31, 2023 or any future period.
Fiscal Period	The Company’s fiscal year ends on January 31. References to fiscal 2023, for example, refer to the fiscal year ending January 31, 2023.
Reclassification	Certain reclassifications of components of prior period investing cash flows have been made in the condensed consolidated statements of cash flows to conform to the current period presentation. These reclassifications had no impact on the aggregate cash flow classifications as previously reported.
Use of Estimates	The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on other assumptions that its management believes are reasonable under the circumstances. Actual results could vary from those estimates. The Company’s most significant estimates include the stand-alone selling price (“SSP”) for each distinct performance obligation included in customer contracts with multiple performance obligations, the determination of the period of benefit for deferred commissions, the determination of the incremental borrowing rate used for operating lease liabilities, the valuation of deferred income tax assets, the valuation of goodwill and acquired intangible assets and their useful lives and the valuation of certain equity awards assumed.
Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted	Recently Adopted Accounting Pronouncements ASU No. 2020-06 The Company adopted the FASB issued ASU No. 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), effective February 1, 2022, using the modified retrospective method. The prior period condensed consolidated financial statements have not been retrospectively adjusted and continue to be reported under the accounting standards in effect for those periods. ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity’s own equity. Among other changes, ASU 2020-06 removes from GAAP the liability and equity separation model for convertible instruments with a cash conversion feature, and as a result, after adoption, no longer requires separately presenting in equity an embedded conversion feature for such debt. Similarly, the embedded conversion feature is no longer amortized into income as interest expense over the life of the instrument. Instead, the convertible debt instrument is accounted for wholly as debt unless (1) a convertible instrument contains features that require bifurcation as a derivative, or (2) a convertible debt instrument was issued at a substantial premium. Additionally, ASU 2020-06 requires the application of the if-converted method to calculate the impact of convertible instruments on diluted earnings per share, which is consistent with the Company’s accounting treatment prior to the adoption of ASU 2020-06. The Company recognized a cumulative effect of initially applying the ASU as an adjustment to the February 1, 2022 opening balance of accumulated deficit. Due to the elimination of the equity conversion component of the Company’s convertible senior notes outstanding as of February 1, 2022, additional paid-in capital was reduced. The elimination of the equity conversion component had the effect of increasing the Company’s net debt balance. The reduction of other liabilities is related to changes to the Company’s deferred tax liabilities. ASU No. 2021-08 The Company adopted the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (“ASU 2021-08”), effective February 1, 2022, on a prospective basis. The update requires contract assets and contract liabilities acquired in a business combination be recognized and measured in accordance with ASC Topic 606, Revenue from Contracts with Customers. The adoption of ASU 2021-08 did not have a material impact on the Company’s condensed consolidated financial statements. ASU No. 2021-04 The Company adopted the FASB issued ASU No. 2021-04, Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (“ASU 2021-04”), effective February 1, 2022, on a prospective basis. ASU 2021-04 addresses specific guidance related to modifications or exchanges of freestanding equity-classified written call options (such as warrants) by specifying the accounting for various modification scenarios. The adoption of ASU 2021-04 did not have a material impact on the Company’s condensed consolidated financial statements.

Accounting Standards and Sign_3

Accounting Standards and Significant Accounting Policies (Tables)	9 Months Ended
	Oct. 31, 2022
Accounting Policies [Abstract]
Schedule of Impact of New Accounting Pronouncements	The adoption of ASU 2020-06 resulted in the following changes to the Company’s condensed consolidated balance sheet as of February 1, 2022: Balance at Adjustments from Adoption of ASU 2020-06 Balance at (dollars in thousands) Liabilities Convertible senior notes, net $ 16,194 $ 927 $ 17,121 Convertible senior notes, net, noncurrent 1,815,714 371,527 2,187,241 Other liabilities, noncurrent 31,775 (866) 30,909 Stockholders’ equity Additional paid-in capital 7,749,716 (527,444) 7,222,272 Accumulated deficit (1,815,867) 155,856 (1,660,011)

Cash Equivalents and Investme_2

Cash Equivalents and Investments (Tables)	9 Months Ended
	Oct. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Schedule of Amortized Costs, Unrealized Gains and Losses and Estimated Fair Value of Cash Equivalents and Short-term Investments	The following tables present the amortized cost, unrealized gain (loss) and estimated fair value of cash equivalents and short-term investments: As of October 31, 2022 Amortized Cost Unrealized Gain Unrealized Loss Estimated Fair Value (dollars in thousands) Cash equivalents: Money market funds $ 91,598 $ — $ — $ 91,598 Total cash equivalents 91,598 — — 91,598 Short-term investments: U.S. treasury securities 2,032,380 — (34,840) 1,997,540 Corporate debt securities 229,491 — (3,493) 225,998 Total short-term investments 2,261,871 — (38,333) 2,223,538 Total $ 2,353,469 $ — $ (38,333) $ 2,315,136 As of January 31, 2022 Amortized Cost Unrealized Gain Unrealized Loss Estimated Fair Value (dollars in thousands) Cash equivalents: Money market funds $ 152,223 $ — $ — $ 152,223 Total cash equivalents 152,223 — — 152,223 Short-term investments: U.S. treasury securities 1,922,344 10 (10,166) 1,912,188 Corporate debt securities 331,050 — (1,581) 329,469 Total short-term investments 2,253,394 10 (11,747) 2,241,657 Total $ 2,405,617 $ 10 $ (11,747) $ 2,393,880
Schedule of Contractual Maturities of Short-term Investments	The following table presents the contractual maturities of the Company’s short-term investments: As of October 31, 2022 Amortized Cost Estimated Fair Value (dollars in thousands) Due within one year $ 1,925,930 $ 1,896,477 Due between one to five years 335,941 327,061 Total $ 2,261,871 $ 2,223,538
Schedule of Unrealized Loss Position and Fair Value of Debt Securities	The following table presents the fair values and unrealized losses related to the Company’s investments in available-for-sale debt securities classified by length of time that the securities have been in a continuous unrealized loss position as of October 31, 2022: Less Than 12 Months More Than 12 Months Total Estimated Fair Value Unrealized Losses Estimated Fair Value Unrealized Losses Estimated Fair Value Unrealized Losses (dollars in thousands) U.S. treasury securities $ 1,129,711 $ (19,305) $ 867,829 $ (15,535) $ 1,997,540 $ (34,840) Corporate debt securities 66,040 (1,035) 159,958 (2,458) 225,998 (3,493) Total $ 1,195,751 $ (20,340) $ 1,027,787 $ (17,993) $ 2,223,538 $ (38,333)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Oct. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following tables present information about the Company’s financial assets that were measured at fair value on a recurring basis using the above input categories: As of October 31, 2022 Level 1 Level 2 Level 3 Total (dollars in thousands) Assets: Cash equivalents: Money market funds $ 91,598 $ — $ — $ 91,598 Total cash equivalents 91,598 — — 91,598 Short-term investments: U.S. treasury securities — 1,997,540 — 1,997,540 Corporate debt securities — 225,998 — 225,998 Total short-term investments — 2,223,538 — 2,223,538 Total cash equivalents and short-term investments $ 91,598 $ 2,223,538 $ — $ 2,315,136 As of January 31, 2022 Level 1 Level 2 Level 3 Total (dollars in thousands) Assets: Cash equivalents: Money market funds $ 152,223 $ — $ — $ 152,223 Total cash equivalents 152,223 — — 152,223 Short-term investments: U.S. treasury securities — 1,912,188 — 1,912,188 Corporate debt securities — 329,469 — 329,469 Total short-term investments — 2,241,657 — 2,241,657 Total cash equivalents and short-term investments $ 152,223 $ 2,241,657 $ — $ 2,393,880
Schedule of Carrying Amounts and Estimated Fair Values of Convertible Note	The following table presents the principal amounts and estimated fair values of the Company’s financial instruments that are not recorded at fair value on the condensed consolidated balance sheets: As of October 31, 2022 Principal Amount Estimated Fair Value (dollars in thousands) 2023 convertible senior notes $ 5,226 $ 6,001 2025 convertible senior notes 1,059,997 887,747 2026 convertible senior notes 1,150,000 925,635

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets, net (Tables)	9 Months Ended
	Oct. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets, net	Intangible assets consisted of the following: As of October 31, 2022 Gross Accumulated Amortization Net (dollars in thousands) Capitalized internal-use software costs $ 48,016 $ (28,607) $ 19,409 Purchased developed technology 219,800 (81,187) 138,613 Customer relationships 140,900 (52,798) 88,102 Trade name 21,400 (6,420) 14,980 Software licenses 1,797 (1,076) 721 $ 431,913 $ (170,088) $ 261,825 As of January 31, 2022 Gross Accumulated Amortization Net (dollars in thousands) Capitalized internal-use software costs $ 36,319 $ (24,170) $ 12,149 Purchased developed technology 219,100 (47,085) 172,015 Customer relationships 140,900 (26,399) 114,501 Trade name 21,400 (3,210) 18,190 Software licenses 116 (3) 113 $ 417,835 $ (100,867) $ 316,968 The weighted-average remaining useful lives of the Company’s acquired intangible assets are as follows: Weighted-Average Remaining Useful Life As of October 31, 2022 As of January 31, 2022 Purchased developed technology 3.3 years 4.0 years Customer relationships 3.5 years 4.0 years Trade name 3.5 years 4.3 years

Convertible Senior Notes, Net (

Convertible Senior Notes, Net (Tables)	9 Months Ended
	Oct. 31, 2022
Debt Disclosure [Abstract]
Schedule of Interest Expense	As of October 31, 2022, the effective interest rate on the 2023 Notes was 0.85%. As of October 31, 2021, prior to the adoption of ASU 2020-06, the effective interest rate on the liability component of the 2023 Notes was 5.68%. The following table sets forth total interest expense recognized related to the 2023 Notes: Three Months Ended Nine Months Ended 2022 2021 2022 2021 (dollars in thousands) Contractual interest expense $ 3 $ 9 $ 14 $ 43 Amortization of debt issuance costs 8 22 35 84 Amortization of debt discount (1) — 213 — 837 Total $ 11 $ 244 $ 49 $ 964 (1) Not applicable subsequent to adoption of ASU 2020-06. As of October 31, 2022, the effective interest rate on the 2025 Notes was 0.43%. As of October 31, 2021, prior to the adoption of ASU 2020-06, the effective interest rate on the liability component of the 2025 Notes was 4.10%. The following table sets forth total interest expense recognized related to the 2025 Notes: Three Months Ended Nine Months Ended 2022 2021 2022 2021 (dollars in thousands) Contractual interest expense $ 332 $ 332 $ 994 $ 994 Amortization of debt issuance costs 809 581 2,424 1,705 Amortization of debt discount (1) — 8,878 — 26,368 Total $ 1,141 $ 9,791 $ 3,418 $ 29,067 (1) Not applicable subsequent to adoption of ASU 2020-06. As of October 31, 2022, the effective interest rate on the 2026 Notes was 0.60%. As of October 31, 2021, prior to the adoption of ASU 2020-06, the effective interest rate on the liability component of the 2026 Notes was 5.75%. The following table sets forth total interest expense recognized related to the 2026 Notes: Three Months Ended Nine Months Ended 2022 2021 2022 2021 (dollars in thousands) Contractual interest expense $ 1,078 $ 1,078 $ 3,234 $ 3,234 Amortization of debt issuance costs 628 364 1,881 1,056 Amortization of debt discount (1) — 11,640 — 34,428 Total $ 1,706 $ 13,082 $ 5,115 $ 38,718 (1) Not applicable subsequent to adoption of ASU 2020-06.
Schedule of Liability and Equity Component of Notes	The net carrying amount of the 2023 Notes consisted of the following: As of October 31, 2022 As of January 31, 2022 (dollars in thousands) Liability component: Principal $ 5,226 $ 17,228 Less: unamortized debt issuance costs and debt discount (1) (9) (1,034) Net carrying amount $ 5,217 $ 16,194 As of October 31, 2022 As of January 31, 2022 (dollars in thousands) Equity component: (1) 2023 Notes $ — $ 3,993 Less: issuance costs — (116) Carrying amount of the equity component (2) $ — $ 3,877 (1) Subsequent to the adoption of ASU 2020-06 under the modified retrospective method, the equity component and debt discount are eliminated. (2) Included in the January 31, 2022 condensed consolidated balance sheet within Additional paid-in capital. The net carrying amount of the 2025 Notes consisted of the following: As of October 31, 2022 As of January 31, 2022 (dollars in thousands) Liability component: Principal $ 1,059,997 $ 1,059,997 Less: unamortized debt issuance costs and debt discount (1) (9,239) (149,333) Net carrying amount $ 1,050,758 $ 910,664 As of October 31, 2022 As of January 31, 2022 (dollars in thousands) Equity component: (1) 2025 Notes $ — $ 221,387 Less: issuance costs — (4,040) Carrying amount of the equity component (2) $ — $ 217,347 (1) Subsequent to the adoption of ASU 2020-06 under the modified retrospective method, the equity component and debt discount are eliminated. (2) Included in the January 31, 2022 condensed consolidated balance sheet within Additional paid-in capital. The net carrying amount of the 2026 Notes consisted of the following: As of October 31, 2022 As of January 31, 2022 (dollars in thousands) Liability component: Principal $ 1,150,000 $ 1,150,000 Less: unamortized debt issuance costs and debt discount (1) (9,211) (244,950) Net carrying amount $ 1,140,789 $ 905,050 As of October 31, 2022 As of January 31, 2022 (dollars in thousands) Equity component: (1) 2026 Notes $ — $ 310,311 Less: issuance costs — (4,090) Carrying amount of the equity component (2) $ — $ 306,221 (1) Subsequent to the adoption of ASU 2020-06 under the modified retrospective method, the equity component and debt discount are eliminated. (2) Included in the January 31, 2022 condensed consolidated balance sheet within Additional paid-in capital.

Leases (Tables)

Leases (Tables)	9 Months Ended
	Oct. 31, 2022
Leases [Abstract]
Schedule of Operating Lease Costs	Operating lease costs were as follows: Three Months Ended Nine Months Ended 2022 2021 2022 2021 (dollars in thousands) Operating lease cost (1) $ 10,218 $ 9,677 $ 30,954 $ 28,135 (1) Amounts are presented exclusive of sublease income and include leases with an original term of 12 months or less (short-term leases), which are immaterial.
Schedule of Maturities of Operating Leases	Maturities of the Company’s operating lease liabilities, which do not include short-term leases, are as follows: As of October 31, 2022 Fiscal Year Ending January 31: (dollars in thousands) 2023 (remaining three months) $ 11,367 2024 44,971 2025 41,540 2026 31,309 2027 30,500 Thereafter 53,608 Total lease payments 213,295 Less imputed interest (27,876) Less tenant improvement allowances not yet recognized (1,979) Total operating lease liabilities $ 183,440

Employee Incentive Plans (Table

Employee Incentive Plans (Tables)	9 Months Ended
	Oct. 31, 2022
Share-Based Payment Arrangement [Abstract]
Schedule of Stock-based Compensation Expense by Statement of Operations Location	Stock-based compensation expense was recorded in the following cost and expense categories in the Company’s condensed consolidated statements of operations: Three Months Ended Nine Months Ended 2022 2021 2022 2021 (dollars in thousands) Cost of revenue Subscription $ 17,106 $ 13,455 $ 51,509 $ 33,843 Professional services and other 3,563 3,376 11,016 8,879 Research and development 69,208 56,573 208,330 129,998 Sales and marketing 41,515 39,248 120,299 101,602 General and administrative 39,593 43,133 120,533 133,289 Total $ 170,985 $ 155,785 $ 511,687 $ 407,611
Schedule of Shares of Common Stock Reserved for Future Issuance	Shares of common stock reserved for future issuance are as follows: As of October 31, 2022 Stock options and unvested RSUs outstanding 15,807,738 Available for future stock option and RSU grants 26,022,656 Available for ESPP 7,053,433 48,883,827
Schedule of Stock Option Activity	A summary of the Company’s stock option activity and related information is as follows: Number of Options Weighted- Average Exercise Price Weighted- Average Remaining Contractual Term (Years) Aggregate Intrinsic Value (in thousands) Outstanding as of January 31, 2022 7,984,078 $ 39.59 5.2 $ 1,314,031 Granted — — Exercised (1,177,880) 12.41 Expired (24,833) 195.71 Forfeited (151,841) 62.73 Outstanding as of October 31, 2022 6,629,524 $ 43.30 4.6 $ 249,207 As of October 31, 2022 Vested and exercisable 5,855,640 $ 27.07 4.1 $ 242,916
Schedule of Nonvested Restricted Stock Units Activity	A summary of the Company’s RSU activity (inclusive of market-based RSUs) and related information is as follows: Number of Weighted- Outstanding as of January 31, 2022 6,225,747 $ 207.26 Granted 6,087,249 121.08 Vested (1,956,194) 177.54 Forfeited (1,178,588) 195.91 Outstanding as of October 31, 2022 9,178,214 $ 157.90
Schedule of ESPP Black-Scholes Option Pricing Model Estimated Fair Value Assumptions	The Company estimated the fair value of ESPP purchase rights using a Black-Scholes option pricing model with the following assumptions: Three Months Ended Nine Months Ended 2022 2021 2022 2021 Expected volatility —%- —% —% - —% 63% - 78% 47% - 48% Expected term (in years) 0 - 0 0 - 0 0.5 - 1.0 0.5 - 1.0 Risk-free interest rate —% - —% —% - —% 2.46% - 2.92% 0.06% - 0.09% Expected dividend yield — — — —

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	9 Months Ended
	Oct. 31, 2022
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Net Loss Per Share	The following table presents the calculation of basic and diluted net loss per share: Three Months Ended Nine Months Ended 2022 2021 2022 2021 Class A Class B Class A Class B Class A Class B Class A Class B (dollars in thousands, except per share data) Numerator: Net loss $ (199,456) $ (9,441) $ (211,176) $ (10,135) $ (632,425) $ (29,657) $ (576,106) $ (31,119) Denominator: Weighted-average shares outstanding, basic and diluted 151,535 7,173 146,715 7,041 150,296 7,048 138,311 7,471 Net loss per share, basic and diluted $ (1.32) $ (1.32) $ (1.44) $ (1.44) $ (4.21) $ (4.21) $ (4.17) $ (4.17)
Schedule of Potentially Dilutive Securities Excluded from Diluted Per Share Calculation	Potentially dilutive securities that are not included in the diluted per share calculations because they would be anti-dilutive are as follows: As of October 31, 2022 2021 (in thousands) Issued and outstanding stock options 6,630 8,621 Unvested RSUs issued and outstanding 9,120 5,221 Unvested market-based RSUs issued and outstanding 116 — Unvested restricted stock awards issued and outstanding 743 1,269 Shares committed under the ESPP 597 213 Shares related to the 2023 Notes 108 356 Shares subject to warrants related to the issuance of the 2023 Notes 1,048 1,048 Shares related to the 2025 Notes 5,617 5,617 Shares related to the 2026 Notes 4,820 4,820 28,799 27,165

Accounting Standards and Sign_4

Accounting Standards and Significant Accounting Policies (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021	Jan. 31, 2022
Liabilities
Convertible senior notes, net	$ 5,217		$ 5,217		$ 16,194
Convertible senior notes, net, noncurrent	2,191,547		2,191,547		1,815,714
Other liabilities, noncurrent	18,392		18,392		31,775
Stockholders’ equity:
Additional paid-in capital	7,785,753		7,785,753		7,749,716
Accumulated deficit	(2,322,093)		(2,322,093)		(1,815,867)
Interest expense decrease	$ (2,805)	$ (23,144)	$ (8,588)	$ (68,776)
Net loss per share, basic, decrease (in dollars per share)	$ 1.32	$ 1.44	$ 4.21	$ 4.17
Net loss per share, diluted, decrease (in dollars per share)	$ 1.32	$ 1.44	$ 4.21	$ 4.17
Adjustment
Liabilities
Convertible senior notes, net					927
Convertible senior notes, net, noncurrent					371,527
Other liabilities, noncurrent					(866)
Stockholders’ equity:
Additional paid-in capital					(527,444)
Accumulated deficit					155,856
Interest expense decrease	$ 21,200		$ 63,000
Net loss per share, basic, decrease (in dollars per share)	$ 0.13		$ 0.40
Net loss per share, diluted, decrease (in dollars per share)	$ 0.13		$ 0.40
Cumulative Effect, Period of Adoption, Adjusted Balance
Liabilities
Convertible senior notes, net					17,121
Convertible senior notes, net, noncurrent					2,187,241
Other liabilities, noncurrent					30,909
Stockholders’ equity:
Additional paid-in capital					7,222,272
Accumulated deficit					$ (1,660,011)

Business Combinations (Details)

Business Combinations (Details) - USD ($) $ in Thousands, shares in Millions			9 Months Ended
	Aug. 02, 2021	May 03, 2021	Oct. 31, 2021	Oct. 31, 2022	Jan. 31, 2022
Business Acquisition [Line Items]
Goodwill				$ 5,400,275	$ 5,401,343
Auth0
Business Acquisition [Line Items]
Consideration transferred		$ 5,671,000
Equity consideration (in shares)		19.2
Cash consideration		$ 257,000
Cash consideration held back		$ 3,800
Equity consideration held back (in shares)		1.1
Equity consideration held back		$ 294,600
Acquisition related costs			$ 29,000
Goodwill		5,290,100
Auth0 | Common stock
Business Acquisition [Line Items]
Equity consideration		5,175,600
Auth0 | Stock options
Business Acquisition [Line Items]
Equity consideration		$ 238,400
atSpoke
Business Acquisition [Line Items]
Consideration transferred	$ 79,300
Cash consideration held back	13,400
Acquisition related costs			$ 900
Goodwill	$ 62,200
Cash consideration hold back period	18 months
atSpoke | Purchased developed technology
Business Acquisition [Line Items]
Intangible assets acquired	$ 18,300
Useful life of acquired intangible assets	3 years

Cash Equivalents and Investme_3

Cash Equivalents and Investments - Schedule of Amortized Costs, Unrealized Gains and Losses and Estimated Fair Value of Cash Equivalents and Short-term Investments (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Cash and Cash Equivalents [Line Items]
Amortized Cost	$ 2,353,469	$ 2,405,617
Unrealized Gain	0	10
Unrealized Loss	(38,333)	(11,747)
Estimated Fair Value	2,315,136	2,393,880
Cash Equivalents
Cash and Cash Equivalents [Line Items]
Amortized Cost	91,598	152,223
Unrealized Gain	0	0
Unrealized Loss	0	0
Estimated Fair Value	91,598	152,223
Cash Equivalents | Money market funds
Cash and Cash Equivalents [Line Items]
Amortized Cost	91,598	152,223
Unrealized Gain	0	0
Unrealized Loss	0	0
Estimated Fair Value	91,598	152,223
Short-term Investments
Cash and Cash Equivalents [Line Items]
Amortized Cost	2,261,871	2,253,394
Unrealized Gain	0	10
Unrealized Loss	(38,333)	(11,747)
Estimated Fair Value	2,223,538	2,241,657
Short-term Investments | U.S. treasury securities
Cash and Cash Equivalents [Line Items]
Amortized Cost	2,032,380	1,922,344
Unrealized Gain	0	10
Unrealized Loss	(34,840)	(10,166)
Estimated Fair Value	1,997,540	1,912,188
Short-term Investments | Corporate debt securities
Cash and Cash Equivalents [Line Items]
Amortized Cost	229,491	331,050
Unrealized Gain	0	0
Unrealized Loss	(3,493)	(1,581)
Estimated Fair Value	$ 225,998	$ 329,469

Cash Equivalents and Investme_4

Cash Equivalents and Investments - Schedule of Contractual Maturities of Short-term Investments (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Amortized Cost
Amortized Cost	$ 2,353,469	$ 2,405,617
Estimated Fair Value
Estimated fair value	2,315,136	2,393,880
Short-term Investments
Amortized Cost
Amortized cost, due within one year	1,925,930
Amortized cost, due between one to five years	335,941
Amortized Cost	2,261,871	2,253,394
Estimated Fair Value
Estimated fair value, due within one year	1,896,477
Estimated fair value, due between one to five years	327,061
Estimated fair value	$ 2,223,538	$ 2,241,657

Cash Equivalents and Investme_5

Cash Equivalents and Investments - Narrative (Details)	9 Months Ended	12 Months Ended
	Oct. 31, 2022 USD ($) investment	Jan. 31, 2022 USD ($) investment
Investments, Debt and Equity Securities [Abstract]
Interest receivable	$ 8,900,000	$ 6,000,000
Number of short-term investments in unrealized loss positions (in investments) | investment	189	193
Other-than-temporary impairment short term investment	$ 0	$ 0
Strategic investments without a readily determinable fair value	$ 23,600,000	$ 15,300,000

Cash Equivalents and Investme_6

Cash Equivalents and Investments - Schedule of Unrealized Loss Position and Fair Value of Debt Securities (Details) $ in Thousands	Oct. 31, 2022 USD ($)
Schedule of Investments [Line Items]
Estimated Fair Value, Less Than 12 Months	$ 1,195,751
Unrealized Losses, Less Than 12 Months	(20,340)
Estimated Fair Value, More Than 12 Months	1,027,787
Unrealized Losses, More Than 12 Months	(17,993)
Estimated Fair Value	2,223,538
Unrealized Losses	(38,333)
U.S. treasury securities
Schedule of Investments [Line Items]
Estimated Fair Value, Less Than 12 Months	1,129,711
Unrealized Losses, Less Than 12 Months	(19,305)
Estimated Fair Value, More Than 12 Months	867,829
Unrealized Losses, More Than 12 Months	(15,535)
Estimated Fair Value	1,997,540
Unrealized Losses	(34,840)
Corporate debt securities
Schedule of Investments [Line Items]
Estimated Fair Value, Less Than 12 Months	66,040
Unrealized Losses, Less Than 12 Months	(1,035)
Estimated Fair Value, More Than 12 Months	159,958
Unrealized Losses, More Than 12 Months	(2,458)
Estimated Fair Value	225,998
Unrealized Losses	$ (3,493)

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - Recurring - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Assets:
Cash equivalents, fair value	$ 91,598	$ 152,223
Short term investments, fair value	2,223,538	2,241,657
Total cash equivalents and short-term investments	2,315,136	2,393,880
U.S. treasury securities
Assets:
Short term investments, fair value	1,997,540	1,912,188
Corporate debt securities
Assets:
Short term investments, fair value	225,998	329,469
Money market funds
Assets:
Cash equivalents, fair value	91,598	152,223
Level 1
Assets:
Cash equivalents, fair value	91,598	152,223
Short term investments, fair value	0	0
Total cash equivalents and short-term investments	91,598	152,223
Level 1 | U.S. treasury securities
Assets:
Short term investments, fair value	0	0
Level 1 | Corporate debt securities
Assets:
Short term investments, fair value	0	0
Level 1 | Money market funds
Assets:
Cash equivalents, fair value	91,598	152,223
Level 2
Assets:
Cash equivalents, fair value	0	0
Short term investments, fair value	2,223,538	2,241,657
Total cash equivalents and short-term investments	2,223,538	2,241,657
Level 2  | U.S. treasury securities
Assets:
Short term investments, fair value	1,997,540	1,912,188
Level 2  | Corporate debt securities
Assets:
Short term investments, fair value	225,998	329,469
Level 2  | Money market funds
Assets:
Cash equivalents, fair value	0	0
Level 3
Assets:
Cash equivalents, fair value	0	0
Short term investments, fair value	0	0
Total cash equivalents and short-term investments	0	0
Level 3 | U.S. treasury securities
Assets:
Short term investments, fair value	0	0
Level 3 | Corporate debt securities
Assets:
Short term investments, fair value	0	0
Level 3 | Money market funds
Assets:
Cash equivalents, fair value	$ 0	$ 0

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of Carrying Amounts and Estimated Fair Values of Convertible Note (Details) - Senior Notes $ in Thousands	Oct. 31, 2022 USD ($)
Net Carrying Amount | 2023 convertible senior notes
Debt Instrument [Line Items]
Convertible senior notes	$ 5,226
Net Carrying Amount | 2025 convertible senior notes
Debt Instrument [Line Items]
Convertible senior notes	1,059,997
Net Carrying Amount | 2026 convertible senior notes
Debt Instrument [Line Items]
Convertible senior notes	1,150,000
Estimated Fair Value | 2023 convertible senior notes
Debt Instrument [Line Items]
Convertible senior notes	6,001
Estimated Fair Value | 2025 convertible senior notes
Debt Instrument [Line Items]
Convertible senior notes	887,747
Estimated Fair Value | 2026 convertible senior notes
Debt Instrument [Line Items]
Convertible senior notes	$ 925,635

Deferred Commissions (Details)

Deferred Commissions (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Revenue from Contract with Customer [Abstract]
Sales commissions capitalized as contract costs	$ 32.5	$ 35.7	$ 81.9	$ 90.6
Amortization of contract costs	$ 21.3	$ 14.9	$ 60.8	$ 40

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets, net - Narrative (Details) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021	Jan. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 5,400,275,000		$ 5,400,275,000		$ 5,401,343,000
Goodwill impairments	0	$ 0	0	$ 0
Intangible amortization expense	$ 23,300,000	$ 22,400,000	$ 69,200,000	$ 46,600,000

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets, net - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Oct. 31, 2022	Jan. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Gross	$ 431,913	$ 417,835
Accumulated Amortization	(170,088)	(100,867)
Net	261,825	316,968
Capitalized internal-use software costs
Finite-Lived Intangible Assets [Line Items]
Gross	48,016	36,319
Accumulated Amortization	(28,607)	(24,170)
Net	19,409	12,149
Purchased developed technology
Finite-Lived Intangible Assets [Line Items]
Gross	219,800	219,100
Accumulated Amortization	(81,187)	(47,085)
Net	$ 138,613	$ 172,015
Weighted-Average Remaining Useful Life	3 years 3 months 18 days	4 years
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross	$ 140,900	$ 140,900
Accumulated Amortization	(52,798)	(26,399)
Net	$ 88,102	$ 114,501
Weighted-Average Remaining Useful Life	3 years 6 months	4 years
Trade name
Finite-Lived Intangible Assets [Line Items]
Gross	$ 21,400	$ 21,400
Accumulated Amortization	(6,420)	(3,210)
Net	$ 14,980	$ 18,190
Weighted-Average Remaining Useful Life	3 years 6 months	4 years 3 months 18 days
Software licenses
Finite-Lived Intangible Assets [Line Items]
Gross	$ 1,797	$ 116
Accumulated Amortization	(1,076)	(3)
Net	$ 721	$ 113

Deferred Revenue and Performa_2

Deferred Revenue and Performance Obligations (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue from remaining performance obligations	$ 2,852.8		$ 2,852.8
Subscription
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue recognized that was included in the contract liability balance	417.8	$ 299.9	858	$ 459.4
Professional services and other
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue recognized that was included in the contract liability balance	5.9	$ 4.5	12.9	$ 5.9
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-11-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue from remaining performance obligations	$ 1,579.4		$ 1,579.4
Remaining performance obligation, percentage	55%		55%
Performance obligations expected to be satisfied, expected timing	12 months		12 months

Convertible Senior Notes, Net -

Convertible Senior Notes, Net - Narrative (Details) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended	9 Months Ended		12 Months Ended
	Oct. 31, 2022 USD ($) tradingDay $ / shares shares	Oct. 31, 2022 USD ($) $ / shares shares	Oct. 31, 2021 shares	Jan. 31, 2022 USD ($) shares	Aug. 15, 2018
Debt Instrument [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)		28,799	27,165
2023 convertible senior notes
Debt Instrument [Line Items]
Number of shares available for purchase (in shares)	100	100
Limitation on sale of common stock due to sale price threshold (in days) | tradingDay	80
Value of shares issuable under warrants granted (in dollars per share) | $ / shares	$ 68.06	$ 68.06
Number of warrants issued subject to anti-dilution adjustments (in shares)	1,000	1,000
2023 convertible senior notes | Shares related to convertible senior notes
Debt Instrument [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)		108	356
2025 convertible senior notes
Debt Instrument [Line Items]
Initial cap price of capped calls (in dollars per share) | $ / shares		$ 255.88
2025 convertible senior notes | Shares related to convertible senior notes
Debt Instrument [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)		5,617	5,617
2026 convertible senior notes
Debt Instrument [Line Items]
Initial cap price of capped calls (in dollars per share) | $ / shares		$ 360.14
2026 convertible senior notes | Shares related to convertible senior notes
Debt Instrument [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)		4,820	4,820
Senior Notes | 2023 convertible senior notes
Debt Instrument [Line Items]
Fixed interest rate					0.25%
Aggregate principal amount | $	$ 5,226	$ 5,226		$ 17,228
Original debt amount | $		$ 12,000		23,000
Effective interest rate	0.85%	0.85%	5.68%
Conversion price (in dollars per share) | $ / shares	$ 48.36	$ 48.36
Hedge exercised and net-share-settled, consideration received on transaction | $		$ 12,000
Senior Notes | 2025 convertible senior notes
Debt Instrument [Line Items]
Fixed interest rate	0.125%	0.125%
Aggregate principal amount | $	$ 1,059,997	$ 1,059,997		1,059,997
Effective interest rate	0.43%	0.43%	4.10%
Conversion price (in dollars per share) | $ / shares	$ 188.71	$ 188.71
Senior Notes | 2026 convertible senior notes
Debt Instrument [Line Items]
Fixed interest rate	0.375%	0.375%
Aggregate principal amount | $	$ 1,150,000	$ 1,150,000		$ 1,150,000
Effective interest rate	0.60%	0.60%	5.75%
Conversion price (in dollars per share) | $ / shares	$ 238.60	$ 238.60
Class A Common Stock | Senior Notes | 2023 convertible senior notes
Debt Instrument [Line Items]
Shares issued during the period		200		500
Hedge exercised and net-share-settled, consideration received on transaction (in shares)		100

Convertible Senior Notes, Net_2

Convertible Senior Notes, Net - Schedule of Interest Expense (Details) - Senior Notes - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
2023 convertible senior notes
Debt Instrument [Line Items]
Contractual interest expense	$ 3	$ 9	$ 14	$ 43
Amortization of debt issuance costs	8	22	35	84
Amortization of debt discount		213		837
Total	11	244	49	964
2025 convertible senior notes
Debt Instrument [Line Items]
Contractual interest expense	332	332	994	994
Amortization of debt issuance costs	809	581	2,424	1,705
Amortization of debt discount		8,878		26,368
Total	1,141	9,791	3,418	29,067
2026 convertible senior notes
Debt Instrument [Line Items]
Contractual interest expense	1,078	1,078	3,234	3,234
Amortization of debt issuance costs	628	364	1,881	1,056
Amortization of debt discount		11,640		34,428
Total	$ 1,706	$ 13,082	$ 5,115	$ 38,718

Convertible Senior Notes, Net_3

Convertible Senior Notes, Net - Schedule of Liability and Equity Component of Notes (Details) - Senior Notes - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
2023 convertible senior notes
Liability component:
Principal	$ 5,226	$ 17,228
Less: unamortized debt issuance costs and debt discount	(9)	(1,034)
Net carrying amount	5,217	16,194
2025 convertible senior notes
Liability component:
Principal	1,059,997	1,059,997
Less: unamortized debt issuance costs and debt discount	(9,239)	(149,333)
Net carrying amount	1,050,758	910,664
2026 convertible senior notes
Liability component:
Principal	1,150,000	1,150,000
Less: unamortized debt issuance costs and debt discount	(9,211)	(244,950)
Net carrying amount	$ 1,140,789	905,050
Additional Paid-in Capital | 2023 convertible senior notes
Equity component:
Equity component		3,993
Less: issuance costs		(116)
Carrying amount of the equity component		3,877
Additional Paid-in Capital | 2025 convertible senior notes
Equity component:
Equity component		221,387
Less: issuance costs		(4,040)
Carrying amount of the equity component		217,347
Additional Paid-in Capital | 2026 convertible senior notes
Equity component:
Equity component		310,311
Less: issuance costs		(4,090)
Carrying amount of the equity component		$ 306,221

Leases - Schedule of Operating

Leases - Schedule of Operating Lease Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Lease cost:
Operating lease cost	$ 10,218	$ 9,677	$ 30,954	$ 28,135

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021	Jan. 31, 2022
Leases [Abstract]
Weighted average remaining lease term	5 years 3 months 18 days		5 years 3 months 18 days		5 years 10 months 24 days
Weighted average discount rate	5.30%		5.30%		5.50%
Cash payments included in the measurement of operating lease liabilities	$ 11,300	$ 10,300	$ 29,500	$ 29,400
Lease impairment charges	$ 14,200		$ 14,461	$ 0

Leases - Schedule of Maturities

Leases - Schedule of Maturities of Operating Leases (Details) $ in Thousands	Oct. 31, 2022 USD ($)
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
2023 (remaining three months)	$ 11,367
2024	44,971
2025	41,540
2026	31,309
2027	30,500
Thereafter	53,608
Total lease payments	213,295
Less imputed interest	(27,876)
Less tenant improvement allowances not yet recognized	(1,979)
Total operating lease liabilities	$ 183,440

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($)	1 Months Ended
	Jul. 31, 2022	Oct. 31, 2022	Jan. 31, 2022
Other Commitments [Line Items]
Long-term purchase commitment	$ 450,000,000
Long-term purchase commitment, period	4 years
Letter of Credit
Other Commitments [Line Items]
Letters of credit issued and outstanding		$ 8,500,000	$ 8,600,000
Draws on line of credit		0	0
Restricted cash, noncurrent		$ 6,300,000	$ 6,400,000

Employee Incentive Plans - Sche

Employee Incentive Plans - Schedule of Stock-based Compensation Expense by Statement of Operations Location (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 170,985	$ 155,785	$ 511,687	$ 407,611
Subscription
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	17,106	13,455	51,509	33,843
Professional services and other
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	3,563	3,376	11,016	8,879
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	69,208	56,573	208,330	129,998
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	41,515	39,248	120,299	101,602
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 39,593	$ 43,133	$ 120,533	$ 133,289

Employee Incentive Plans - Narr

Employee Incentive Plans - Narrative (Details) $ / shares in Units, $ in Millions	1 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2022 $ / shares shares	Oct. 31, 2022 USD ($) numberOfIncentivePlan period $ / shares shares	Jan. 31, 2022 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of equity incentive plans (in incentive plans) | numberOfIncentivePlan		2
Options to purchase common stock outstanding (in shares)		6,629,524	7,984,078
Unrecognized stock-based compensation expense related to stock options | $		$ 112.5
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average stock-based compensation recognition period		1 year 10 months 24 days
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average stock-based compensation recognition period		3 years 1 month 6 days
Unrecognized compensation costs related to unvested restricted stock units | $		$ 1,304
Number of shares granted in period		6,087,249
Granted (in dollars per share) | $ / shares		$ 121.08
Market-based RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted in period	58,150
Award vesting period	3 years
Granted (in dollars per share) | $ / shares	$ 244.73
Market-based RSUs | Performance period one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	33%
Market-based RSUs | Performance period two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	33%
Market-based RSUs | Performance period three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	33%
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average stock-based compensation recognition period		7 months 6 days
Unrecognized compensation costs related to unvested restricted stock units | $		$ 15.2
Consecutive offering period		12 months
Number of purchase periods | period		2
Purchase period		6 months
Shares of employee purchased Class A common stock (in shares)		269,814
Weighted-average purchase price of employee purchased Class A common stock (in dollars per share) | $ / shares		$ 70.27
Total proceeds from employee purchase of Class A common stock | $		$ 19
Minimum | Market-based RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Earn rate, percent of shares granted	0%
Maximum | Market-based RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Earn rate, percent of shares granted	200%
Auth0 and atSpoke | Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average stock-based compensation recognition period		1 year 6 months
Unrecognized compensation costs related to unvested restricted stock units | $		$ 172.4
Number of shares granted in period			1,269,008
Award vesting period			3 years
Granted (in dollars per share) | $ / shares			$ 268.98
2017 Equity Incentive Plan | Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options to purchase common stock outstanding (in shares)		1,841,836
2017 Equity Incentive Plan | Class B Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options to purchase common stock outstanding (in shares)		4,787,688

Employee Incentive Plans - Sc_2

Employee Incentive Plans - Schedule of Common Stock Reserved for Future Issuance (Details)	Oct. 31, 2022 shares
Class of Stock [Line Items]
Common stock reserved for future issuance and options and unvested RSUs outstanding (in shares)	48,883,827
Stock Options and Restricted Stock Units
Class of Stock [Line Items]
Stock options and unvested RSUs outstanding (in shares)	15,807,738
Common stock, reserved for future issuance (in shares)	26,022,656
ESPP
Class of Stock [Line Items]
Common stock, reserved for future issuance (in shares)	7,053,433

Employee Incentive Plans - Sc_3

Employee Incentive Plans - Schedule of Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Oct. 31, 2022	Jan. 31, 2022
Number of Options
Number of options, outstanding beginning of period (in shares)	7,984,078
Number of options, granted (in shares)	0
Number of options, exercised (in shares)	(1,177,880)
Number of options, expired (in shares)	(24,833)
Number of options, forfeited (in shares)	(151,841)
Number of options, outstanding end of period (in shares)	6,629,524	7,984,078
Vested and exercisable, number of options (in shares)	5,855,640
Weighted- Average Exercise Price
Options outstanding, weighted average exercise price beginning of period (in dollars per share)	$ 39.59
Options granted, weighted average exercise price (in dollars per share)	0
Options exercised, weighted average exercise price (in dollars per share)	12.41
Options expired, weighted average exercise price (in dollars per share)	195.71
Options forfeited, weighted average exercise price (in dollars per share)	62.73
Options outstanding, weighted average exercise price end of period (in dollars per share)	43.30	$ 39.59
Vested and exercisable, weighted average exercise price (in dollars per share)	$ 27.07
Additional Disclosures
Options outstanding, weighted average remaining contractual term	4 years 7 months 6 days	5 years 2 months 12 days
Options outstanding, aggregate intrinsic value	$ 249,207	$ 1,314,031
Vested and exercisable, weighted average remaining contractual term	4 years 1 month 6 days
Vested and exercisable, aggregate intrinsic value	$ 242,916

Employee Incentive Plans - Sc_4

Employee Incentive Plans - Schedule of Restricted Stock Unit Activity (Details) - RSUs	9 Months Ended
	Oct. 31, 2022 $ / shares shares
Number of RSUs
Beginning balance (in shares) | shares	6,225,747
Granted (in shares) | shares	6,087,249
Vested (in shares) | shares	(1,956,194)
Forfeited (in shares) | shares	(1,178,588)
Ending balance (in shares) | shares	9,178,214
Weighted- Average Grant Date Fair Value Per Share
Beginning balance (in dollars per share) | $ / shares	$ 207.26
Granted (in dollars per share) | $ / shares	121.08
Vested (in dollars per share) | $ / shares	177.54
Forfeited (in dollars per share) | $ / shares	195.91
Ending balance (in dollars per share) | $ / shares	$ 157.90

Employee Incentive Plans - Sc_5

Employee Incentive Plans - Schedule of Estimated Fair Value Assumptions (Details)	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility			63%	47%
Expected term (in years)			6 months	6 months
Risk-free interest rate			2.46%	0.06%
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility			78%	48%
Expected term (in years)			1 year	1 year
Risk-free interest rate			2.92%	0.09%
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend yield	0%	0%	0%	0%
ESPP | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	0%	0%
Expected term (in years)	0 years	0 years
Risk-free interest rate	0%	0%
ESPP | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	0%	0%
Expected term (in years)	0 years	0 years
Risk-free interest rate	0%	0%

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Income Tax Disclosure [Abstract]
Provision for (benefit from) income taxes	$ 3,728	$ 667	$ 9,804	$ (6,785)
Pretax losses	$ 205,169	$ 220,644	$ 652,278	$ 614,010
Effective income tax rate	(1.80%)	(0.30%)	(1.50%)	1.10%

Net Loss Per Share - Schedule o

Net Loss Per Share - Schedule of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Numerator:
Net loss	$ (208,897)	$ (221,311)	$ (662,082)	$ (607,225)
Denominator:
Weighted-average shares outstanding, basic (in shares)	158,708	153,756	157,344	145,782
Weighted-average shares outstanding, diluted (in shares)	158,708	153,756	157,344	145,782
Net loss per share, basic (in dollars per share)	$ (1.32)	$ (1.44)	$ (4.21)	$ (4.17)
Net loss per share, diluted (in dollars per share)	$ (1.32)	$ (1.44)	$ (4.21)	$ (4.17)
Class A Common Stock
Numerator:
Net loss	$ (199,456)	$ (211,176)	$ (632,425)	$ (576,106)
Denominator:
Weighted-average shares outstanding, basic (in shares)	151,535	146,715	150,296	138,311
Weighted-average shares outstanding, diluted (in shares)	151,535	146,715	150,296	138,311
Net loss per share, basic (in dollars per share)	$ (1.32)	$ (1.44)	$ (4.21)	$ (4.17)
Net loss per share, diluted (in dollars per share)	$ (1.32)	$ (1.44)	$ (4.21)	$ (4.17)
Class B Common Stock
Numerator:
Net loss	$ (9,441)	$ (10,135)	$ (29,657)	$ (31,119)
Denominator:
Weighted-average shares outstanding, basic (in shares)	7,173	7,041	7,048	7,471
Weighted-average shares outstanding, diluted (in shares)	7,173	7,041	7,048	7,471
Net loss per share, basic (in dollars per share)	$ (1.32)	$ (1.44)	$ (4.21)	$ (4.17)
Net loss per share, diluted (in dollars per share)	$ (1.32)	$ (1.44)	$ (4.21)	$ (4.17)

Net Loss Per Share - Schedule_2

Net Loss Per Share - Schedule of Potentially Dilutive Securities Excluded from Computation of Diluted Per Share (Details) - shares shares in Thousands	9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	28,799	27,165
Issued and outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	6,630	8,621
Unvested RSUs issued and outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	9,120	5,221
Unvested market-based RSUs issued and outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	116	0
Unvested restricted stock awards issued and outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	743	1,269
Shares committed under the ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	597	213
Shares related to convertible senior notes | 2023 convertible senior notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	108	356
Shares related to convertible senior notes | 2025 convertible senior notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	5,617	5,617
Shares related to convertible senior notes | 2026 convertible senior notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	4,820	4,820
Shares subject to warrants related to the issuance of the 2023 Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	1,048	1,048

Net Loss Per Share - Narrative

Net Loss Per Share - Narrative (Details)	Oct. 31, 2022 $ / shares
2023 convertible senior notes
Debt Instrument [Line Items]
Value of shares issuable under warrants granted (in dollars per share)	$ 68.06